Active ingredient
Xenon
10 finished FDA listings contain Xenon as their only active ingredient; 1 combination products also contain it.
FDA NDC Directory
- Ingredient names as written by FDA
- XENON XE-129, XENON XE-129, HYPERPOLARIZED, XENON XE-133
- Dosage forms
- Gas
- Routes
- Respiratory (Inhalation)
- Manufacturers / labelers
- 4
- Strengths listed
- 10 mci/1 · 10 mci/ml · 20 mci/1 · 5 mci/ml · 75 ml/300ml · 75 ml/500ml · 75 ml/750ml · 75 ml/l
- Brand names in FDA listings
- Xenon, Xenon, Xe-133, Xenoview
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 11363
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 017284 | SHINE | 1974-10-10 | 4 |
| NDA 018327 | CURIUM | 1982-03-09 | 2 |
| NDA 214375 | POLAREAN | 2022-12-23 | 4 |
Official labeling on DailyMed
- XENON (XENON XE-133) GAS [SHINE SPECT USA, LLC] · version 2 · 2026-09-11
- XENOVIEW (XENON XE 129 HYPERPOLARIZED) GAS [POLAREAN, INC.] · version 5 · 2025-06-18
- XENON, XE-133 (XENON) GAS [CURIUM US LLC] · version 20 · 2024-10-18
- XENON (XENON XE-133) GAS [LANTHEUS MEDICAL IMAGING, INC.] · version 17 · 2022-11-30
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.